Literature DB >> 33034825

BsmI-ApaI-TaqI TAC (BAt) Haplotype of Vitamin D Receptor Gene Is Associated with Increased Risk of Major Depressive Disorder.

Munn-Sann Lye1,2, Yin-Sim Tor3,4, Yin-Yee Tey3, Aishah Shahabudin3, Su-Peng Loh5, Normala Ibrahim6, Johnson Stanslas7, Rozita Rosli8, King-Hwa Ling8.   

Abstract

Heritability of major depressive disorder (MDD) is between 36 and 44%, suggesting that up to nearly half of the phenotypic variability is attributable to genes. A number of genetic polymorphisms have been shown to predispose certain individuals to depression. Of particular interest are the polymorphisms of the vitamin D receptor (VDR) gene. Although the VDR gene has been well characterized and a vast number of polymorphisms have been identified, the association between BsmI (rs1544410), ApaI (rs7975232) and TaqI (rs731236) single-nucleotide polymorphisms (SNPs), together with their haplotypes, and MDD risk have yet to be established. We conducted a matched case-control study with a total of 600 participants comprising 300 major depressive disorder (MDD) cases and 300 controls matched by age, gender and ethnicity in a 1:1 ratio, in four public hospitals in Kuala Lumpur and Selangor. Three adjacent SNPs of the VDR gene-BsmI (rs1544410), ApaI (rs7975232) and TaqI (rs731236)-were genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Odds ratios and 95% confidence intervals (CIs) were obtained from conditional logistic regression using Stata 16. Linkage disequilibrium and haplotype association with MDD were analyzed using the online SNPStats program. None of the genotypes of the three SNPs was significantly associated with risk of developing MDD after adjusting for confounding factors. However, the TAC (BAt) haplotype was associated with increased odds of MDD (adjusted OR = 2.17, 95% CI = 1.30-3.61, p = 0.003) using CCT (baT) as reference haplotype. The findings suggest that the BsmI-ApaI-TaqI TAC (BAt) haplotype of the VDR gene increases susceptibility to MDD.

Entities:  

Keywords:  Case–control study; Genetic polymorphism; Haplotype; Major depressive disorder; Vitamin D receptor (VDR) gene

Year:  2020        PMID: 33034825     DOI: 10.1007/s12031-020-01719-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene.

Authors:  M B Demay; M S Kiernan; H F DeLuca; H M Kronenberg
Journal:  Mol Endocrinol       Date:  1992-04

2.  Vitamin D Levels and Vitamin D Receptor Gene Polymorphism in Major Depression.

Authors:  Merve Şahin Can; Hayriye Baykan; Özgür Baykan; Nevin Erensoy; Tunay Karlıdere
Journal:  Psychiatr Danub       Date:  2017-06       Impact factor: 1.063

3.  Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.

Authors:  T Carling; P Ridefelt; P Hellman; J Rastad; G Akerström
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

4.  Cloning and expression of full-length cDNA encoding human vitamin D receptor.

Authors:  A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples.

Authors:  Richard Border; Emma C Johnson; Luke M Evans; Andrew Smolen; Noah Berley; Patrick F Sullivan; Matthew C Keller
Journal:  Am J Psychiatry       Date:  2019-03-08       Impact factor: 18.112

6.  Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment.

Authors:  Shelli Avenevoli; Joel Swendsen; Jian-Ping He; Marcy Burstein; Kathleen Ries Merikangas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-10-29       Impact factor: 8.829

7.  Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability.

Authors:  L K Durrin; R W Haile; S A Ingles; G A Coetzee
Journal:  Biochim Biophys Acta       Date:  1999-03-30

8.  Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function.

Authors:  Francine Côté; Etienne Thévenot; Cécile Fligny; Yves Fromes; Michèle Darmon; Marie-Anne Ripoche; Elisa Bayard; Naima Hanoun; Francoise Saurini; Philippe Lechat; Luisa Dandolo; Michel Hamon; Jacques Mallet; Guilan Vodjdani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

9.  Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.

Authors:  T Carling; J Rastad; G Akerström; G Westin
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

10.  Cross-national epidemiology of DSM-IV major depressive episode.

Authors:  Evelyn Bromet; Laura Helena Andrade; Irving Hwang; Nancy A Sampson; Jordi Alonso; Giovanni de Girolamo; Ron de Graaf; Koen Demyttenaere; Chiyi Hu; Noboru Iwata; Aimee N Karam; Jagdish Kaur; Stanislav Kostyuchenko; Jean-Pierre Lépine; Daphna Levinson; Herbert Matschinger; Maria Elena Medina Mora; Mark Oakley Browne; Jose Posada-Villa; Maria Carmen Viana; David R Williams; Ronald C Kessler
Journal:  BMC Med       Date:  2011-07-26       Impact factor: 8.775

View more
  2 in total

Review 1.  The relationship between vitamin D receptor gene polymorphisms and ankylosing spondylitis: a systematic review, meta-analysis and trial sequential analysis.

Authors:  Hang Zhou; Bo-Yang Zhou; Su-Rong Liang; Min Li; Jian Zhao
Journal:  Rheumatol Int       Date:  2022-08-23       Impact factor: 3.580

Review 2.  Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety.

Authors:  Bruna R Kouba; Anderson Camargo; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.